(University of Texas M. D. Anderson Cancer Center) Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from the University of Texas M.
D. Anderson Cancer Center report in Clinical Cancer Research.
Post new comment